Biofil Chemicals and Pharmaceuticals last traded at ₹30.60 (2026-10-13). Over the past month the stock moved -15.0%, three months the stock moved -17.5%, year the stock moved -29.4%. Its closing range over 52 weeks is ₹27.52 – ₹39.48, with the latest close 22.5% below the high.
Closing prices up to 2026-10-13.
Incorporated in 1993, Biofil Chemicals and Pharmaceuticals Ltd deals in Pharmaceuticals and Chemicals products.[1]
Business Overview:[1] BCPL is engaged in diverse pharmaceutical activities including manufacture and trading of various pharmaceutical and chemical products. It also deals in providing job work facility in respect of manufacturing of pharmaceuticals drug. The company runs its business via 2 units viz. Pharmaceutical Division & Chemicals Division.
In the latest quarter (Jun 2026), Biofil Chemicals and Pharmaceuticals reported sales of ₹12.35 crore (+92.1%) and net profit of ₹0.11 crore (-95.4%), compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Jun 2026 | 12.35 | 0.14 | 1.13 | 0.11 | 0.07 |
| Mar 2026 | 7.57 | 0.43 | 5.68 | 0.21 | 0.13 |
| Dec 2025 | 0.86 | 0.09 | 10.47 | 0.08 | 0.05 |
| Sep 2025 | 13.54 | 0.12 | 0.89 | 0.08 | 0.05 |
| Jun 2025 | 6.43 | 0.01 | 0.16 | 2.41 | 1.48 |
| Mar 2025 | 8.35 | 0.11 | 1.32 | 0.20 | 0.12 |
| Dec 2024 | 14.20 | 0.31 | 2.18 | 0.16 | 0.10 |
| Sep 2024 | 2.41 | 0.12 | 4.98 | 0.02 | 0.01 |
| Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | -86.1% | +182.3% | -45.1% | -23.8% | +461.8% | -93.9% | -9.3% | +92.1% |
| Operating profit growth | -50.0% | +63.2% | – | -96.8% | +0.0% | -71.0% | +290.9% | +1300.0% |
| Net profit growth | -83.3% | +77.8% | -20.0% | +1317.6% | +300.0% | -50.0% | +5.0% | -95.4% |
| EPS growth | -85.7% | +66.7% | -20.0% | +1380.0% | +400.0% | -50.0% | +8.3% | -95.3% |
| OPM % | 5.0% | 2.2% | 1.3% | 0.2% | 0.9% | 10.5% | 5.7% | 1.1% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
In the latest year (Mar 2026), Biofil Chemicals and Pharmaceuticals reported sales of ₹28.40 crore (-15.0%) and net profit of ₹2.79 crore (+398.2%), compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 28.40 | 0.65 | 2.29 | 2.79 | 1.71 |
| Mar 2025 | 33.40 | 0.85 | 2.54 | 0.56 | 0.34 |
| Mar 2024 | 40.04 | 0.81 | 2.02 | 0.71 | 0.44 |
| Mar 2023 | 30.04 | 1.16 | 3.86 | 0.56 | 0.34 |
| Mar 2022 | 22.38 | 1.33 | 5.94 | 0.70 | 0.43 |
| Mar 2021 | 35.75 | 1.60 | 4.48 | 1.24 | 0.76 |
| Mar 2020 | 29.69 | 1.82 | 6.13 | 1.21 | 0.74 |
| Mar 2019 | 23.13 | 1.02 | 4.41 | 0.48 | 0.29 |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +87.1% | +28.4% | +20.4% | -37.4% | +34.2% | +33.3% | -16.6% | -15.0% |
| Operating profit growth | +9.7% | +78.4% | -12.1% | -16.9% | -12.8% | -30.2% | +4.9% | -23.5% |
| Net profit growth | +2.1% | +152.1% | +2.5% | -43.5% | -20.0% | +26.8% | -21.1% | +398.2% |
| EPS growth | +0.0% | +155.2% | +2.7% | -43.4% | -20.9% | +29.4% | -22.7% | +402.9% |
| OPM % | 4.4% | 6.1% | 4.5% | 5.9% | 3.9% | 2.0% | 2.5% | 2.3% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
No AI analysis generated yet for Biofil Chemicals and Pharmaceuticals.
Get Free AI Stock Analysis FREE →Biofil Chemicals and Pharmaceuticals Issues Mandatory KYC Update Notice to Physical Shareholders - scanx.trade
Biofil Chemicals and Pharmaceuticals shares were last quoted at ₹30.60 (+1.5% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
Biofil Chemicals and Pharmaceuticals has a price-to-earnings (P/E) ratio of 105.03 and a price-to-book (P/B) ratio of 2.37. The industry P/E is 52.82.
The 52-week high of Biofil Chemicals and Pharmaceuticals is ₹46.82 and the 52-week low is ₹25.60.
The market capitalisation of Biofil Chemicals and Pharmaceuticals is about ₹51.28 crore.
In the latest quarter (Jun 2026), Biofil Chemicals and Pharmaceuticals reported sales of ₹12.35 crore (+92.1%) and net profit of ₹0.11 crore (-95.4%), compared with the same quarter last year.
This page is for information and is not investment advice. As per the data shown here, Biofil Chemicals and Pharmaceuticals has a 3-year ROE of 7.00%, 3-year profit growth of 71.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
Promoters hold about 46.79% of Biofil Chemicals and Pharmaceuticals.
Biofil Chemicals and Pharmaceuticals belongs to the Pharmaceuticals & Drugs sector.